Prospect of the use of checkpoint inhibitors in hepatocellular cancer treatments

References

• LlovetJMRicciSMazzaferroVSorafenib in advanced hepa-tocellular carcinomaN Engl J Med2008359437839018650514
   PubMed Web of Science ®Google Scholar
• BlankCUHaanenJBRibasASchumacherTNCancer immunology. The “cancer immunogram”Science2016352628665866027151852
   PubMed Web of Science ®Google Scholar
• BowenDGZenMHolzLDavisTMcCaughanGWBertolinoPThe site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunityJ Clin Invest2004114570171215343389
   PubMed Web of Science ®Google Scholar
• ThomsonAWKnollePAAntigen-presenting cell function in the tolerogenic liver environmentNat Rev Immunol2010101175376620972472
   PubMed Web of Science ®Google Scholar
• OrmandyLAHillemannTWedemeyerHMannsMPGretenTFKorangyFIncreased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinomaCancer Res20056562457246415781662
   PubMed Web of Science ®Google Scholar
• ChenKJLinSZZhouLSelective recruitment of regulatory T cell through CCR6-CCL20 in hepatocellular carcinoma fosters tumor progression and predicts poor prognosisPLoS One201169e2467121935436
   PubMed Web of Science ®Google Scholar
• GaoQQiuSJFanJIntratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resectionJ Clin Oncol200725182586259317577038
   PubMed Web of Science ®Google Scholar
• HoechstBVoigtlaenderTOrmandyLMyeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptorHepatology200950379980719551844
   PubMed Web of Science ®Google Scholar
• AlisaAIvesAPathanAAAnalysis of CD4+ T-cell responses to a novel alpha-fetoprotein-derived epitope in hepatocellular carcinoma patientsClin Cancer Res200511186686669416166448
   PubMed Web of Science ®Google Scholar
• ZabalaMLasarteJJPerretCInduction of immunosuppressive molecules and regulatory T cells counteracts the antitumor effect of interleukin-12-based gene therapy in a transgenic mouse model of liver cancerJ Hepatol200747680781517935823
   PubMed Web of Science ®Google Scholar
• GretenTFOrmandyLAFikuartALow-dose cyclophosphamide treatment impairs regulatory T cells and unmasks AFP-specific CD4+ T-cell responses in patients with advanced HCCJ Immunother201033221121820139774
   PubMed Web of Science ®Google Scholar
• WildinRSRamsdellFPeakeJX-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfyNat Genet2001271182011137992
   PubMed Web of Science ®Google Scholar
• BennettCLChristieJRamsdellFThe immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3Nat Genet2001271202111137993
   PubMed Web of Science ®Google Scholar
• UnittERushbrookSMMarshallACompromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cellsHepatology200541472273015791620
   PubMed Web of Science ®Google Scholar
• YangXHYamagiwaSIchidaTIncrease of CD4+ CD25+ regulatory T-cells in the liver of patients with hepatocellular carcinomaJ Hepatol200645225426216600416
   PubMed Web of Science ®Google Scholar
• ShenXLiNLiHZhangTWangFLiQIncreased prevalence of regulatory T cells in the tumor microenvironment and its correlation with TNM stage of hepatocellular carcinomaJ Cancer Res Clin Oncol2010136111745175420221638
   PubMed Web of Science ®Google Scholar
• KobayashiNHiraokaNYamagamiWFOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesisClin Cancer Res200713390291117289884
   PubMed Web of Science ®Google Scholar
• FuJXuDLiuZIncreased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patientsGastroenterology200713272328233917570208
   PubMed Web of Science ®Google Scholar
• ZhouJDingTPanWZhuLYLiLZhengLIncreased intratumoral regulatory T cells are related to intratumoral macrophages and poor prognosis in hepatocellular carcinoma patientsInt J Cancer200912571640164819569243
   PubMed Web of Science ®Google Scholar
• MuellerMMFusenigNEConstitutive expression of G-CSF and GM-CSF in human skin carcinoma cells with functional consequence for tumor progressionInt J Cancer199983678078910597195
   PubMed Web of Science ®Google Scholar
• von BoehmerHMechanisms of suppression by suppressor T cellsNat Immunol20056433834415785759
   PubMed Web of Science ®Google Scholar
• GretenTFMannsMPKorangyFMyeloid derived suppressor cells in human diseasesInt Immunopharmacol201111780280721237299
   PubMed Web of Science ®Google Scholar
• GabrilovichDIOstrand-RosenbergSBronteVCoordinated regulation of myeloid cells by tumoursNat Rev Immunol201212425326822437938
   PubMed Web of Science ®Google Scholar
• HoechstBOrmandyLABallmaierMA new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cellsGastroenterology2008135123424318485901
   PubMed Web of Science ®Google Scholar
• IlkovitchDLopezDMThe liver is a site for tumor-induced myeloid-derived suppressor cell accumulation and immunosuppressionCancer Res200969135514552119549903
   PubMed Web of Science ®Google Scholar
• AriharaFMizukoshiEKitaharaMIncrease in CD14+HLA-DR -/low myeloid-derived suppressor cells in hepatocellular carcinoma patients and its impact on prognosisCancer Immunol Immunother20136281421143023764929
   PubMed Web of Science ®Google Scholar
• CaiLZhangZZhouLFunctional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patientsClin Immunol2008129342843718824414
   PubMed Web of Science ®Google Scholar
• HanYChenZYangYHuman CD14+ CTLA-4+ regulatory dendritic cells suppress T-cell response by cytotoxic T-lymphocyte antigen-4-dependent IL-10 and indoleamine-2,3-dioxygenase production in hepatocellular carcinomaHepatology201459256757923960017
   PubMed Web of Science ®Google Scholar
• ShirabeKManoYMutoJRole of tumor-associated macrophages in the progression of hepatocellular carcinomaSurg Today20124211722116397
   PubMed Web of Science ®Google Scholar
• KuangDMZhaoQPengCActivated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1J Exp Med200920661327133719451266
   PubMed Web of Science ®Google Scholar
• KuangDMPengCZhaoQTumor-activated monocytes promote expansion of IL-17-producing CD8+ T cells in hepatocellular carcinoma patientsJ Immunol201018531544154920581151
   PubMed Web of Science ®Google Scholar
• ZhuXDZhangJBZhuangPYHigh expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinomaJ Clin Oncol200826162707271618509183
   PubMed Web of Science ®Google Scholar
• KuangDMZhaoQWuYPeritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinomaJ Hepatol201154594895521145847
   PubMed Web of Science ®Google Scholar
• MazzoccaADituriFLupoLQuarantaMAntonaciSGiannelliGTumor-secreted lysophostatidic acid accelerates hepatocellular carcinoma progression by promoting differentiation of peritumoral fibroblasts in myofibroblastsHepatology201154392093021674557
   PubMed Web of Science ®Google Scholar
• KojimaYAcarAEatonENAutocrine TGF-beta and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblastsProc Natl Acad Sci U S A201010746200092001421041659
   PubMed Web of Science ®Google Scholar
• HodiFSO’DaySJMcDermottDFImproved survival with ipilimumab in patients with metastatic melanomaN Engl J Med2010363131290
   Web of Science ®Google Scholar
• TatsumiTTakeharaTKatayamaKExpression of costimulatory molecules B7-1 (CD80) and B7-2 (CD86) on human hepatocellular carcinomaHepatology1997255110811149141426
   PubMed Web of Science ®Google Scholar
• ShiFShiMZengZPD-1 and PD-L1 upregulation promotes CD8(+) T-cell apoptosis and postoperative recurrence in hepatocellular carcinoma patientsInt J Cancer2011128488789620473887
   PubMed Web of Science ®Google Scholar
• LiFJZhangYJinGXYaoLWuDQExpression of LAG-3 is coincident with the impaired effector function of HBV-specific CD8(+) T cell in HCC patientsImmunol Lett20131501–211612223261718
   PubMed Web of Science ®Google Scholar
• LiHWuKTaoKTim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinomaHepatology20125641342135122505239
   PubMed Web of Science ®Google Scholar
• StemmerSMBenjaminovOMedaliaGCF102 for the treatment of hepatocellular carcinoma: a phase I/II, open-label, dose-escalation studyOncologist2013181252623299770
   PubMed Web of Science ®Google Scholar
• Pedroza-GonzalezAKwekkeboomJSprengersDT-cell suppression mediated by regulatory T cells infiltrating hepatic tumors can be overcome by GITRL treatmentOncoimmunology201321e2245023483229
   PubMed Web of Science ®Google Scholar
• Pedroza-GonzalezAZhouGSinghSPGITR engagement in combination with CTLA-4 blockade completely abrogates immunosuppression mediated by human liver tumor-derived regulatory T cells ex vivoOncoimmunology2015412e105129726587321
   PubMed Web of Science ®Google Scholar
• MeleroIHervas-StubbsSGlennieMPardollDMChenLImmunostimulatory monoclonal antibodies for cancer therapyNat Rev Cancer2007729510617251916
   PubMed Web of Science ®Google Scholar
• HoosAIbrahimRKormanADevelopment of ipilimumab: contribution to a new paradigm for cancer immunotherapySemin Oncol201037553354621074069
   PubMed Web of Science ®Google Scholar
• WeberJImmune checkpoint proteins: a new therapeutic paradigm for cancer – preclinical background: CTLA-4 and PD-1 blockadeSemin Oncol201037543043921074057
   PubMed Web of Science ®Google Scholar
• LinsleyPSBradyWUrnesMGrosmaireLSDamleNKLedbetterJACTLA-4 is a second receptor for the B cell activation antigen B7J Exp Med199117435615691714933
   PubMed Web of Science ®Google Scholar
• EngelhardtJJSullivanTJAllisonJPCTLA-4 overexpression inhibits T cell responses through a CD28-B7-dependent mechanismJ Immunol200617721052106116818761
   PubMed Web of Science ®Google Scholar
• WaterhousePPenningerJMTimmsELymphoproliferative disorders with early lethality in mice deficient in Ctla-4Science199527052389859887481803
   PubMed Web of Science ®Google Scholar
• FleckenTSchmidtNHildSImmunodominance and functional alterations of tumor-associated antigen-specific CD8+ T-cell responses in hepatocellular carcinomaHepatology20145941415142624002931
   PubMed Web of Science ®Google Scholar
• GehringAJHoZZTanATProfile of tumor antigen-specific CD8 T cells in patients with hepatitis B virus-related hepatocellular carcinomaGastroenterology2009137268269019394336
   PubMed Web of Science ®Google Scholar
• ChenZShenSPengBTaoJIntratumoural GM-CSF microspheres and CTLA-4 blockade enhance the antitumour immunity induced by thermal ablation in a subcutaneous murine hepatoma modelInt J Hyperthermia200925537438219479598
   PubMed Web of Science ®Google Scholar
• SangroBGomez-MartinCde la MataMA clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis CJ Hepatol2013591818823466307
   PubMed Web of Science ®Google Scholar
• SprinzlMFGallePRFacing the dawn of immunotherapy for hepato-cellular carcinomaJ Hepatol201359191023571018
   PubMed Web of Science ®Google Scholar
• JinHTAndersonACTanWGCooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infectionProc Natl Acad Sci U S A201010733147331473820679213
   PubMed Web of Science ®Google Scholar
• BlackburnSDShinHHainingWNCoregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infectionNat Immunol2009101293719043418
   PubMed Web of Science ®Google Scholar
• IshidaYAgataYShibaharaKHonjoTInduced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell deathEMBO J19921111388738951396582
   PubMed Web of Science ®Google Scholar
• FreemanGJLongAJIwaiYEngagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activationJ Exp Med200019271027103411015443
   PubMed Web of Science ®Google Scholar
• KeirMELiangSCGuleriaITissue expression of PD-L1 mediates peripheral T cell toleranceJ Exp Med2006203488389516606670
   PubMed Web of Science ®Google Scholar
• TsengSYOtsujiMGorskiKB7-DC, a new dendritic cell molecule with potent costimulatory properties for T cellsJ Exp Med2001193783984611283156
   PubMed Web of Science ®Google Scholar
• DongHStromeSESalomaoDRTumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasionNat Med20028879380012091876
   PubMed Web of Science ®Google Scholar
• WangLPino-LagosKde VriesVCGuleriaISayeghMHNoelleRJProgrammed death 1 ligand signaling regulates the generation of adaptive Foxp3+CD4+ regulatory T cellsProc Natl Acad Sci U S A2008105279331933618599457
   PubMed Web of Science ®Google Scholar
• PardollDMThe blockade of immune checkpoints in cancer immunotherapyNat Rev Cancer201212425226422437870
   PubMed Web of Science ®Google Scholar
• WillimskyGSchmidtKLoddenkemperCGellermannJBlankensteinTVirus-induced hepatocellular carcinomas cause antigen-specific local toleranceJ Clin Invest201312331032104323454765
   PubMed Web of Science ®Google Scholar
• WherryEJT cell exhaustionNat Immunol201112649249921739672
   PubMed Web of Science ®Google Scholar
• HofmeyerKAJeonHZangXThe PD-1/PD-L1 (B7-H1) pathway in chronic infection-induced cytotoxic T lymphocyte exhaustionJ Biomed Biotechnol2011201145169421960736
   PubMedGoogle Scholar
• GaoQWangXYQiuSJOverexpression of PD-L1 significantly associates with tumor aggressiveness and postoperative recurrence in human hepatocellular carcinomaClin Cancer Res200915397197919188168
   PubMed Web of Science ®Google Scholar
• El-KhoueiryABMeleroICrocenziTSPhase I/II safety and antitumor activity of nivolumab in patients with advanced hepato-cellular carcinoma (HCC): CA209-040ASCO Meeting Abstracts201533SupplLBA101
   Google Scholar